A

APIM Therapeutics

8 employees

APIM Therapeutics is developing proprietary peptide drugs targeting PCNA (Proliferating Cell Nuclear Antigen).

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
ATX-101
Finance
PCNA & stress responses
Therapeutics
Oncology
Venture Capital

Date founded

2010

Funding rounds raised

A

APIM Therapeutics raised undisclosed on October 17, 2012

Investors: Sarsia, Televenture Management and Sarsia

A

APIM Therapeutics raised undisclosed on November 10, 2011

Investors: Sarsia and Sarsia

FAQ